|
Downgrades: BIIB, JCI, KMP
|
Downgrades: BIIB, JCI, KMP
After Biogen (BIIB) reported better than expected earnings yesterday, BMO downgraded the company from Outperform to Market Perform.  Goldman Sachs disagreed and maintained its Buy rating on the stock, citing the continuing possibility of a buyout by a larger pharmaceutical company making shares attractive at these prices.
Video Length: 0
Date Found: July 17, 2009
Date Produced: July 17, 2009
View Count: 0
|
|
|
|
|
I got punched by an old guy, for farting near his wife. Read MoreComic book creator Stan Lee talks the future of the medium in the digital age. Panelists Zachary... Read MoreThe U.S. launch of Spotify is still on music lovers' minds. Join Zachary Levi, from NBC’s... Read MoreTuesday: Rupert Murdoch testifies before Parliament on the hacking scandal that brought down "News... Read MoreAfter a long slump, the home construction industry may be showing signs of life. But as Bill... Read More | 1 2 3 4 5 |
|
|
|